Champions Oncology (CSBR) Reports Q3 Loss of $0.21/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.86 +0.62%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.21), versus ($0.49) reported last year. Revenue for the quarter came in at $2.6 million, versus $1.8 million reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xperi Corporation (XPER) Tops Q3 EPS by 3c; Offers Guidance
- Acadia Healthcare (ACHC) Tops Q3 EPS by 14c ; Offers Guidance
- TaskUs, Inc. (TASK) Tops Q3 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
